The ‘golden age’ for research tools: Parse Biosciences raises $41.5M for single-cell tech
GeekWire
FEBRUARY 15, 2022
Parse Biosciences CTO Charles Roco and CEO Alex Rosenberg. People have seen how valuable research tools are, in terms of advancing science, medicine and drug discovery,” Rosenberg said in an interview. “It’s There’s a vast range of research questions the approach can help answer. Parse Photo). million in new funding.
91 
Let's personalize your content